Exact Sciences (NASDAQ: EXAS)
Exact Sciences Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Exact Sciences Company Info
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
News & Analysis
1 Beaten-Down Cathie Wood Stock to Buy and Hold
This company is innovating where it matters most, which could prove highly lucrative down the road.
2 Beaten-Down Cathie Wood Stocks With Massive Potential
They won't lag the market forever.
Cathie Wood Is Selling This Stock: Should You?
This company hasn't performed well in the past 12 months.
2 Cathie Wood Growth Stocks to Buy and Hold for the Long Haul
These stocks can reward patient investors.
1 Supercharged Growth Stock to Buy Before It Soars as Much as 222%, According to Cathie Wood's Ark Invest
If the fund manager's calculations prove to be correct, shareholders could enjoy threefold returns over the coming four years. Is she right?
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?
Both of these biotech stocks have been market-beaters over the prior 10 years. One stock, however, is a better buy right now.
2 Revolutionary Stocks That Could Turn $1,000 Into $2,000 by 2030
Don't miss out on these potentially market-beating stocks.
Investing in Biotech ETFs
Here are the five best biotech ETFs to invest in right now.
Valuation
Earnings Transcripts
Exact Sciences (EXAS) Q4 2023 Earnings Call Transcript
EXAS earnings call for the period ending December 31, 2023.
Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript
EXAS earnings call for the period ending September 30, 2023.
Exact Sciences (EXAS) Q2 2023 Earnings Call Transcript
EXAS earnings call for the period ending June 30, 2023.
Exact Sciences (EXAS) Q1 2023 Earnings Call Transcript
EXAS earnings call for the period ending March 31, 2023.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.